Urinary leukotrience E4 Level in children with asthma

HE Mei-Juan, CHEN Qiang, LIU Jian-Mei

Chinese Journal of Contemporary Pediatrics ›› 2009, Vol. 11 ›› Issue (12) : 909-912.

PDF(967 KB)
PDF(967 KB)
Chinese Journal of Contemporary Pediatrics ›› 2009, Vol. 11 ›› Issue (12) : 909-912.
CLINICAL RESEARCH

Urinary leukotrience E4 Level in children with asthma

  • HE Mei-Juan, CHEN Qiang, LIU Jian-Mei
Author information +
History +

Abstract

OBJECTIVE: Cysteinyl leukotriene (CysLTs) plays an important role in airway inflammation and remodeling in asthma. Measurement of urinary leukotriene E4 (LTE4) is a sensitive and noninvasive method of assaying total body CysLTs level. This study aimed to evaluate the clinical significance of urinary leukotriene E4 (LTE4) in childhood asthma. METHODS: Sixty children with acute asthma were randomly divided into montelukast (leukotriene receptor antagonist) treatment and conventional treatment groups (n=30 each). Urinary LTE4 levels were measured using ELISA and the airway resistance Rint was assessed by the lung function instrument at the acute and the convalescence phases. Twenty healthy children were used as the control group. RESULTS: Urinary LTE4 levels in asthmatic children at the acute and the convalescence phases were significantly higher than those in the control group (P<0.01). The urinary LTE4 levels at the convalescence phase were significantly reduced compared with those at the acute phase in asthmatic children (P<0.01). More significantly decreased urinary LTE4 levels were noted in the montelukast treatment group than the conventional treatment group at the convalescence phase (P<0.01). In the acute phase, there was no correlation between urinary LTE4 level and Rint in asthmatic children. CONCLUSIONS: Urinary LTE4 level is significantly increased in children with acute asthma. Urinary LTE4 is a useful marker for the diagnosis of asthma and can be as a predictor of asthma control and marker of susceptibility to treatment with leukotriene receptor antagonists.[Chin J Contemp Pediatr, 2009, 11 (11):909-912]

Key words

Asthma / Urinary leukotriene E4 / Airway resistance / Child

Cite this article

Download Citations
HE Mei-Juan, CHEN Qiang, LIU Jian-Mei. Urinary leukotrience E4 Level in children with asthma[J]. Chinese Journal of Contemporary Pediatrics. 2009, 11(12): 909-912

References

[1]吴婕翎,陈爱欢,彭秋莹,陈荣昌,钟南山.哮喘儿童吸入糖皮质激素疗效与白三烯水平的相关性探讨[J].中国当代儿科杂志,2009,11(6):441-444.
[2]Rabinovitch N. Uninary leukotriene E4[J]. Immunol Allergy Clin North Am, 2007, 27(4):651-654.
[3]中华医学会儿科学分会呼吸学组.儿童支气管哮喘防治常规(试用)[J].中华儿科杂志, 2004, 42(2):100-106.
[4]张建华,张学兰,季正华,盛锦云.支气管哮喘患儿血管紧张素Ⅱ的致炎作用[J]. 实用儿科临床杂志, 2006, 21(4):212-213.
[5]Mita H, Turikisawa N, Yamada T, Taniguchi M. Quantification of leukotriene B4 glucuronide in human urine[J]. Prostaglandins Other Lipid Mediators, 2007, 83(1):42-49.
[6]Smith CM, Hawksworth RJ, Thien FC. Urinary leukotriene E4 in bronchial asthma[J]. Eur Respir J, 1992, 5(6):693-699.
[7]陶哲,喻书彻,杨谊平,王文丽,韩晓娟. 支气管哮喘患儿尿白三烯E4的测定和临床意义[J]. 中国实用儿科杂志, 2004, 19(1):22-24.
[8]Knorr B, Franehi LM, Bissard H, Vermeulen JH, LeSouef  P, Santanello N, et al. Montelukast,a leukotriene receptor antagonist,for the treatment of persistent asthma in children aged 2 to 5 years[J]. Pediatrics, 2005, 108(5):E48.
[9]Stelmach I, Grzelewski T, Bobrowska-Korzeniowska M, Stelmach P, Kuna P.A randomized, double-blind trial of the effect of anti-asthma treatment on lung function in children with  asthma[J].Pulm Pharmacol Therap, 2007, 20(6):691-700.
[10]Kleinman R, Mura M, Liu MY. 半胱氨酰白三烯拮抗剂治疗儿童哮喘[J].中国当代儿科杂志,2005,7(5):398-403.
[11]刘建梅,陈强,朱晓华,吴爱民,李岚,李莉,等.南昌市315名8个月~5 岁正常儿童气道阻力的研究[J].实验与检验医学,2009,27(1):25-26.
[12]沈春荣,汪祝萍,王英姿.阻断法气道阻力测定在2~5岁咳喘儿童中的应用[J].浙江临床医学, 2006, 8(4):346-347.

PDF(967 KB)

Accesses

Citation

Detail

Sections
Recommended

/